These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8369370)

  • 21. Gamma generalized linear models for pharmacokinetic data.
    Salway R; Wakefield J
    Biometrics; 2008 Jun; 64(2):620-6. PubMed ID: 17888039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparing experimental designs for benchmark dose calculations for continuous endpoints.
    Kuljus K; von Rosen D; Sand S; Victorin K
    Risk Anal; 2006 Aug; 26(4):1031-43. PubMed ID: 16948695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimating integrals using quadrature methods with an application in pharmacokinetics.
    Bailer AJ; Piegorsch WW
    Biometrics; 1990 Dec; 46(4):1201-11. PubMed ID: 2085635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioavailability and pharmacokinetics of florfenicol in healthy sheep.
    Shen J; Li X; Jiang H; Hsu WH
    J Vet Pharmacol Ther; 2004 Jun; 27(3):163-8. PubMed ID: 15189302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of human pharmacokinetics using physiologically based modeling: a retrospective analysis of 26 clinically tested drugs.
    De Buck SS; Sinha VK; Fenu LA; Nijsen MJ; Mackie CE; Gilissen RA
    Drug Metab Dispos; 2007 Oct; 35(10):1766-80. PubMed ID: 17620347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Closed-form solutions for the optimum equivalence of first-order compartmental models and their implications for classical models of closed-circuit anesthesia.
    Connor CW; Philip JH
    Physiol Meas; 2009 Feb; 30(2):N11-21. PubMed ID: 19136733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A method for estimating and testing area under the curve in serial sacrifice, batch, and complete data designs.
    Holder DJ; Hsuan F; Dixit R; Soper K
    J Biopharm Stat; 1999 Aug; 9(3):451-64. PubMed ID: 10473031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental design for estimating integrals by numerical quadrature, with applications to pharmacokinetic studies.
    Katz D; D'Argenio DZ
    Biometrics; 1983 Sep; 39(3):621-8. PubMed ID: 6652198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bayesian design criteria: computation, comparison, and application to a pharmacokinetic and a pharmacodynamic model.
    Merlé Y; Mentré F
    J Pharmacokinet Biopharm; 1995 Feb; 23(1):101-25. PubMed ID: 8576840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A model for the experimental evaluation of the absolute bioavailability of drugs--weak organic bases].
    Musin RA; Pentiuk AA
    Eksp Klin Farmakol; 1993; 56(3):64-6. PubMed ID: 8219999
    [No Abstract]   [Full Text] [Related]  

  • 31. [Multivariate data evaluation V. Analysis of time-series (unifactorial model)].
    Mager PP
    Gegenbaurs Morphol Jahrb; 1974; 120(4):485-91. PubMed ID: 4466720
    [No Abstract]   [Full Text] [Related]  

  • 32. Confidence intervals on the ratio of expected mean squares (theta 1 + d theta 2)/theta 3.
    Lu TF; Graybill FA; Burdick RK
    Biometrics; 1987 Sep; 43(3):535-43. PubMed ID: 3663817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A method for statistical comparison of bioavailability when only one concentration-time point per individual is available.
    Jawień W
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):484. PubMed ID: 1490795
    [No Abstract]   [Full Text] [Related]  

  • 34. Estimating bioavailability when clearance changes in time: the effect of model misspecification.
    Fattinger KE; Verotta D
    Clin Pharmacol Ther; 1995 Nov; 58(5):595-600. PubMed ID: 7586955
    [No Abstract]   [Full Text] [Related]  

  • 35. Compartmental analysis revisited.
    Rescigno A
    Pharmacol Res; 1999 Jun; 39(6):471-8. PubMed ID: 10373243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitivity analysis of pharmacokinetic parameters in one-compartment models.
    Wu G
    Pharmacol Res; 2000 Apr; 41(4):445-53. PubMed ID: 10704269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comments on "Analytical Solution to the Three-Compartment Pharmacokinetic Model".
    Larsen JL; Arzbaecher R
    IEEE Trans Biomed Eng; 1989 Nov; 36(11):1141-2. PubMed ID: 2807324
    [No Abstract]   [Full Text] [Related]  

  • 38. Design of experiments for the precise estimation of dose-response parameters: the Hill equation.
    Bezeau M; Endrenyi L
    J Theor Biol; 1986 Dec; 123(4):415-30. PubMed ID: 3657186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-compartmental estimation of pharmacokinetic parameters for flexible sampling designs.
    Jaki T; Wolfsegger MJ
    Stat Med; 2012 May; 31(11-12):1059-73. PubMed ID: 21969306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mathematical models of complex dose-response relationships: implications for experimental design in psychopharmacologic research.
    Faraone SV; Simpson JC; Brown WA
    Stat Med; 1992 Mar; 11(5):685-702. PubMed ID: 1350687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.